Kiadis announces multiple abstracts related to its K-NK-cell therapy platform have been accepted for presentation at TCT, the Combined Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR

Amsterdam, The Netherlands, January 22, 2021 a?? Kiadis Pharma N.V. ("Kiadis" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company developing innovative NK-cell-based medicines for the treatment of life-threatening diseases, today announces that four abstracts related to its K-NK-cell therapy platform were accepted for presentation at the TCT Meetings, the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy (ASTCT) and Center for International Blood & Marrow Transplant Research (CIBMTR), which is being held virtually from February 8a??12, 2021.
The abstracts are now available atA 2021 TCT | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR (confex.com)Details of the oral presentation are as follows:

Oral Presentation #80: Results of a Phase I Study with Mb-IL21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Refractory Acute Myeloid Leukemia
Presenter: Stefan O. Ciurea, MD
Presentation Date: Wednesday, February 10, 2021: 4:45 PM a?? 5:00 PM CST

Details of the poster presentations are as follows:

Poster #172: A Phase I Trial of Incorporating Natural Killer (K-NK) Cells for Patients with Chronic Myeloid Leukemia (CML)and Molecular Residual Disease after Tyrosine Kinase Inhibitor (TKI) Therapy
Presenter: Lindsay Rein, MD
Affiliation: Duke University Medical Center, Durham, NC



Poster #411: A Phase I Clinical Trial Testing the Safety of IL-21-Expanded, Off-the-Shelf, Natural Killer Cells for Relapsed/Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome
Presenter: Sumithira Vasu, MD
Affiliation: The Ohio State University, Columbus, OH



Poster #531 - BMT CTN 1803: Haploidentical Natural Killer Cells (K-NK002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)
Presenter: Sumithira Vasu
Affiliation: The Ohio State University, Columbus, OH

Poster presentations will be on display Monday, February 8 through Friday, February 12, 8:30 AM a?? 5:00 PM CST.